Thalassemia is the most common genetic disease in the world. Blood transfusion and iron chelator remain the main treatment , lacking of effective drug treatment. With the in-depth understanding of the pathogenesis of thalassemia, more and more targets can be used for the treatment, and targeted drugs have been developed continuously, with some of them have entered the clinic. Treatment of thalassemia is moving towards the era of targeted therapy.

无